CircRNA ÇÕ¼º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
CircRNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits), By Application (Therapeutics Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654444
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

CircRNA ÇÕ¼º ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ CircRNA ÇÕ¼º ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 4¾ï 4,250¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2025-2030³â°£ ¿¬Æò±Õ 15.88%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼øÈ¯ RNA ÇÕ¼º »ê¾÷Àº ¼øÈ¯ RNAÀÇ Ä¡·á °¡´É¼ºÀ» °­Á¶ÇÏ´Â Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·Â¿¡ ÈûÀÔ¾î Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù Nature Reviews Genetics¿¡ °ÔÀçµÈ ¼­½Ã¿À °úÇÐÀÚµéÀÇ Á¾ÇÕÀûÀÎ ÃÑÆòÀº Çâ»óµÈ ¾ÈÁ¤¼º°ú ¿ì¼öÇÑ ¸é¿ªÇÐÀû ÇÁ·ÎÆÄÀÏ µî CircRNAÀÇ °íÀ¯ÇÑ Æ¯¼ºÀ» °­Á¶Çϸç, °¨¿°¼º Áúȯ, CAR-T Ä¡·á, À¯ÀüÀÚ Ä¡·á µî ´Ù¾çÇÑ Ä¡·á¿ëµµ¿¡ ´ëÇÑ À¯¸ÁÇÑ Èĺ¸¹°ÁúÀÓÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. µÇ°í ÀÖ½À´Ï´Ù. ÀÌ Ã¥Àº CircRNA Ä¡·áÀÇ ÇöÀç ÁøÀüÀ» °­Á¶ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ÀÌ ºÐ¾ßÀÇ ±âȸ¿Í °úÁ¦¸¦ ¹àÇô ´õ ¸¹Àº ÅõÀÚ¿Í Å½±¸¸¦ Àå·ÁÇϰí ÀÖ½À´Ï´Ù.

±â¾÷ °£ Àü·«Àû Á¦ÈÞµµ ½ÃÀåÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 1¿ù Circio´Â 4basebio¿Í Á¦ÈÞÇÏ¿© À¯ÀüÀÚ ÀÇ·á ¹× ¹é½Å¿ë ÇÕ¼º circVec DNA º¤ÅÍÀÇ °³¹ß ¹× Å×½ºÆ®¸¦ ÁøÇàÇϰí ÀÖ½À´Ï´Ù. À̹ø Á¦ÈÞ´Â CircioÀÇ circVec ¼øÈ¯ RNA ¹ßÇö ½Ã½ºÅÛ°ú 4basebioÀÇ µ¶ÀÚÀûÀÎ ÇÕ¼º DNA Æ÷¸Ë°ú µ¶ÀÚÀûÀÎ ³ª³ëÀÔÀÚ Àü´Þ Ç÷§ÆûÀÎ Hermes¸¦ °áÇÕÇÏ¿© °­·ÂÇÑ Ä¡·á Á¶ÇÕÀ» âÃâÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦ÈÞ´Â ¹Ì·¡ÀÇ ÇÕ¼º DNA À¯ÀüÀÚ Ä¡·á¸¦ À§ÇÑ ³»±¸¼º ÀÖ°í ¹Ýº¹ÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ºñ¹ÙÀÌ·¯½º¼º Ç÷§ÆûÀ» °³¹ßÇÏ´Â µ¥ ÀÖÀ¸¸ç, Áß¿äÇÑ Àǹ̸¦ °®½À´Ï´Ù.

CircRNA »ý»ê ±â¼úÀÇ Çõ½ÅÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 8¿ù Abogen Biosciences´Â Cis-SystemÀ̶ó´Â ¼øÈ¯ RNA »ý»êÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¸Å¿ì È¿À²ÀûÀÎ RNA ¼øÈ¯È­ ½Ã½ºÇöóÀÌ½Ì ½Ã½ºÅÛ °³¹ßÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ µ¶ÀÚÀûÀÎ ½Ã½ºÅÛÀº ¼¼°è ÁöÀûÀç»ê±ÇÀ» °¡Áö°í ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ±âÁ¸ ¹æ¹ýº¸´Ù °³¼±µÇ¾î CircRNA »ý»êÀÇ È¿À²¼º°ú È®À强À» Çâ»ó½Ãų ¼ö ÀÖ´Â °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸´Â CircRNA¸¦ Ä¡·á ¹× ¹é½Å¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇϸç, ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

CircRNA ÇÕ¼º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå CircRNA ÇÕ¼º ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå CircRNA ÇÕ¼º ½ÃÀå : Á¦Ç°¡¤¼­ºñ½ºº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå CircRNA ÇÕ¼º ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå CircRNA ÇÕ¼º ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå CircRNA ÇÕ¼º ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

CircRNA Synthesis Market Growth & Trends:

The global circRNA synthesis market size is anticipated to reach USD 442.5 million by 2030 and grow at a CAGR of 15.88% from 2025 to 2030 during the forecast period, according to a new report by Grand View Research, Inc. The circRNA synthesis industry is experiencing significant growth, driven by ongoing research and development efforts that highlight the therapeutic potential of circular RNAs. A recent comprehensive review published in Nature Reviews Genetics by Circio scientists underscores the unique properties of circRNAs, such as enhanced stability and superior immunological profiles, which make them promising candidates for various therapeutic applications, including infectious diseases, CAR-T therapy, and gene therapy. This publication not only emphasizes the current advancements in circRNA therapeutics but also identifies opportunities and challenges in the field, thereby encouraging further investment and exploration.

Strategic collaborations between companies are also propelling the market forward. For instance, in January 2024, Circio has partnered with 4basebio to develop and test synthetic circVec DNA vectors for genetic medicine and vaccines. This partnership aims to combine Circio's circVec circular RNA expression system with 4basebio's proprietary synthetic DNA formats and unique nanoparticle delivery platform, Hermes, to create a powerful therapeutic combination. Such alliances are instrumental in advancing the development of durable, repeat-dosable, non-viral platforms for future synthetic DNA gene therapies.

Innovations in circRNA production technologies are further driving market expansion. For instance, in August 2024, Abogen Biosciences, has announced the development of a highly efficient RNA circularization cis-splicing system, referred to as the Cis-System, which enables the production of circular RNA. This proprietary system not only holds global intellectual property rights but also offers improvements over existing methods, potentially enhancing the efficiency and scalability of circRNA production. Such technological advancements are crucial for the broader application of circRNA in therapeutics and vaccines, thereby fueling market growth.

CircRNA Synthesis Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. CircRNA Synthesis Market Variables, Trends, & Scope

Chapter 4. CircRNA Synthesis Market: Product & Services Estimates & Trend Analysis

Chapter 5. CircRNA Synthesis Market: Application Estimates & Trend Analysis

Chapter 6. CircRNA Synthesis Market: End Use Estimates & Trend Analysis

Chapter 7. CircRNA Synthesis Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â